PDPL Intraday Analysis...

PDPL Share Price

Open 27.55 Change Price %
High 28.65 1 Day -0.10 -0.36
Low 27.50 1 Week -1.75 -5.88
Close 28.00 1 Month -0.25 -0.88
Volume 13555 1 Year -12.75 -31.29
52 Week High 43.50
52 Week Low 19.30
PDPL Important Levels
Resistance 2 29.07
Resistance 1 28.63
Pivot 28.05
Support 1 27.37
Support 2 26.93
NSE INDIA Most Active Stocks
ADANIENT 114.15 -3.71%
IDFCBANK 65.20 6.54%
SUZLON 20.50 -1.68%
JSWENERGY 66.90 4.94%
GMRINFRA 17.55 2.33%
JPASSOCIAT 13.55 3.44%
IDFC 61.20 4.70%
IBREALEST 156.30 1.46%
SOUTHBANK 24.60 1.86%
SBIN 282.05 -1.54%
More..
NSE INDIA Top Gainers Stocks
LCCINFOTEC 0.25 25.00%
PETRONENGG 175.60 19.99%
FACT 47.75 17.32%
SURYAROSNI 255.80 15.25%
SASKEN 447.75 13.70%
TFL 11.55 12.14%
HEG 315.20 10.25%
HEG 315.20 10.25%
PGIL 132.65 9.40%
BHANDARI 2.95 9.26%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
VISESHINFO 0.15 -25.00%
RAJRAYON 0.20 -20.00%
SHILPI 132.75 -19.98%
NAKODA 0.40 -11.11%
SHARONBIO 7.20 -10.00%
WELINV 117.50 -8.02%
LAKSHVILAS 180.30 -7.77%
TCIDEVELOP 492.10 -7.67%
HIL 797.35 -6.18%
More..

Parenteral Drugs (India) Limited (NSE: PDPL)

PDPL Technical Analysis 3
As on 27th Apr 2017 PDPL Share Price closed @ 28.00 and we RECOMMEND Buy for LONG-TERM with Stoploss of 27.79 & Buy for SHORT-TERM with Stoploss of 26.95 we also expect STOCK to react on Following IMPORTANT LEVELS.
PDPL Target for April
1st Target up-side 29.56
2nd Target up-side 31.36
3rd Target up-side 33.15
1st Target down-side 24.44
2nd Target down-side 22.64
3rd Target down-side 20.85
PDPL Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is 51.22 Sideways
MFI (14) MFI is 74.89 Sideways
CCI (20) CCI is 10.35 Sideways
WILLIAM %R (14) William %R is -67.80 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 26.56
10 Day Avg Volume Traded -89.29 % Less then 10 Day Average Volume
PDPL Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PDPL Address
PDPL
N/A
Interactive Technical Analysis Chart Parenteral Drugs (India) Limited ( PDPL NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parenteral Drugs (India) Limited
PDPL Business Profile
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 112.11 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director. It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Link Intime India Pvt. Ltd.